Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.

MLA

Leblanc, Kori, et al. “Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.” Cancers, vol. 16, no. 19, Oct. 2024, p. 3336. EBSCOhost, https://doi.org/10.3390/cancers16193336.

APA

Leblanc, K., Edwards, S. J., Dranitsaris, G., Leong, D. P., Carrier, M., Malone, S., Rendon, R. A., Bond, A. M., Sitland, T. D., Zalewski, P., Wang, M., & Emmenegger, U. (2024). Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. Cancers, 16(19), 3336. https://doi.org/10.3390/cancers16193336

Chicago

Leblanc, Kori, Scott J. Edwards, George Dranitsaris, Darryl P. Leong, Marc Carrier, Shawn Malone, Ricardo A. Rendon, et al. 2024. “Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.” Cancers 16 (19): 3336. doi:10.3390/cancers16193336.